Prelude Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.17M	Buy	13,909 +486	+4%	+$40.7K	0.11%	226
2025 Q1	$959K	Sell	13,423 -6,893	-34%	-$493K	0.07%	262
2024 Q4	$913K	Buy	+20,316	New	+$913K	0.06%	339